P&G Beats Wall Street Estimates as Tide and Febreze Lift First-Quarter Results

Procter & Gamble opened its new fiscal year with a beat, as strong demand for laundry detergent and home care products pushed quarterly earnings and revenue past Wall Street expectations. The consumer goods giant reported its fiscal first-quarter results on Thursday, and shares rose more than 2% in premarket trading. The results also gave investors a rare dose of volume growth from a company that has fought softer demand from value-conscious shoppers.

Adjusted earnings reached $2.00 per share, ahead of the $1.88 that analysts surveyed by LSEG expected. Revenue came in at $23.3 billion against forecasts of $22.8 billion. Net sales rose 4% from a year earlier, and the company posted volume growth of 2.4%.

Earnings and Revenue Top Forecasts

P&G reported net income attributable to the company of $4.73 billion, or $1.97 per share. That compares with $4.75 billion, or $1.95 per share, a year earlier. Excluding restructuring costs and other items, the company earned $2 per share, a gain of about 1% from the prior year.

Gross margin landed at 49.8%, slightly below the 50% analysts expected. Organic sales growth reached 4%, roughly double the 1.96% estimate. Net sales of $23.28 billion also cleared the $22.82 billion forecast.

The quarter marks a notable turn for a company that has struggled to grow volumes. Like many consumer companies, P&G has watched demand weaken as shoppers grow more value conscious. Executives have said consumers now squeeze every last drop of shampoo or laundry detergent, and value packs have gained popularity. In fiscal 2026, P&G reported just one quarter of volume growth, which makes this start look stronger.

Fabric and Home Care Leads the Portfolio

The fabric and home care division, home to brands such as Tide and Febreze, led the company. Its volume rose 4.3%, and its organic sales growth of 4.8% far exceeded the 2.35% analysts expected. The baby, feminine and family care segment and the beauty business each posted volume growth of more than 2%.

Organic sales growth in those two areas also topped forecasts. Beauty grew 5.4% against an estimate of 3.58%, while baby, feminine and family care rose 3% against an estimate of 0.99%. The grooming segment, which includes Gillette and Venus razors, saw volume slip 0.4%. Even so, its organic sales growth of 4.5% beat the 0.7% estimate by a wide margin.

The health care business was the laggard of the portfolio. Its volume fell 2.9% as demand weakened for oral care products such as Crest toothpaste and personal health items such as Pepto-Bismol. Still, the segment’s organic sales growth of 2.7% edged past the 2.51% forecast.

A Resilient Consumer, With Caveats

P&G’s price increases have not yet crushed a consumer base that is coping with higher inflation. Chief Financial Officer Andre Schulten said the company still sees strength among shoppers.

“The US consumer is remarkably resilient,” P&G CFO Andre Schulten said.

Schulten added that higher-income households are powering the business, while shoppers at the lower end of the income scale are acting more cautiously. That split matters for a company that sells everyday staples across a wide range of price points. It also explains why value packs and careful usage habits remain part of the story even as volumes recover.

Chief Executive Shailesh Jejurikar struck a measured tone in the company’s statement. He said P&G expects continued challenges but remains on course to deliver its targets.

The company is expecting continued “geopolitical and economic challenges,” but P&G is on track to meet its guidance, CEO Shailesh Jejurikar said in a statement.

Fiscal 2027 Outlook Reflects Thorne Deal

For fiscal 2027, P&G reiterated its forecast for core earnings per share in a range of $6.89 to $7.11. Analysts had looked for core earnings of $6.98, which sits near the middle of that range. The company also held its organic sales growth outlook at 1% to 3%, compared with the analyst estimate of 2.19%.

The company did raise its all-in sales growth projection to a range of 2% to 4% from the prior range of 1% to 3%. That change reflects P&G’s acquisition of vitamin company Thorne, which closed on Oct. 1. The deal adds a new wellness brand to the portfolio without altering the company’s organic expectations.

What the Quarter Means for Investors

The report offers reassurance on several fronts. P&G beat on both the top and bottom lines, returned to volume growth, and kept its profit forecast intact despite a cautious lower-income shopper. The slightly softer gross margin and the drop in health care volume remain areas to watch.

For now, the market responded positively, with the stock climbing in early trading. The central question going forward is whether volume growth can persist after a fiscal 2026 in which it appeared in only one quarter. If higher-income households keep spending and lower-income shoppers stay steady, P&G’s brands in laundry, home care and beauty appear well positioned to keep delivering.